Biogen

This Spinal Muscular Atrophy (SMA) Awareness month, Kim shares her passion for adventure and how she is traveling the world with SMA.    Kim is inspiring others to pursue their dreams and discusses how she turns challenges into opportunities to experience the best the world has to offer.    Hear more of her story and travel advice on our website: https://ow.ly/96Jw50SPea3 #SMAAwarenessMonth | #SMA

STARTING SOON: Join our Q2 2024 financial results live webcast at 8:30 AM ET. Join here: https://ow.ly/pwew50SOymX #Earnings | #BIIB | #FinancialResults

Through our research on the role of tau in Alzheimer’s disease, we can learn more about the neurological basis of this debilitating disease and how symptoms arise for patients. Learn more about tau’s role in neurodegenerative diseases. #AlzheimersDisease | #AlzheimersResearch | #AAIC24

Teaching hands-on science for neurodivergent students helps us to contribute to a diverse life sciences pipeline.    Our RTP CoLab was proud to welcome the Durham Public Schools (DPS)'s NeuroDiversity camp to help foster an environment to explore STEM. We look forward to working with DPS, the Autism Society of North Carolina and the North Carolina Business Committee for Education this Disability Pride Month and beyond.    Explore the impact of Biogen’s CoLab: https://ow.ly/GBsT50SOibz   #STEMCareers | #DisabilityPrideMonth | #CaringDeeply 

Today we announced a collaboration with Beckman Coulter Diagnostics and Fujirebio Diagnostics, Inc. to identify and develop blood-based biomarkers for tau pathology in the brain. As leaders in Alzheimer's disease (AD) research and development, we aim to advance new tools that can measure brain tau pathology to potentially stratify patients or monitor treatment response in AD clinical trials.     Learn more here: https://ow.ly/Btmo50SNxNw   #News | #Neuroscience | #AlzheimersDisease 

The lack of diversity in clinical trials is a challenge that needs to be addressed. At Biogen, we’re working to identify and understand how barriers can impact communities’ participation in clinical trials, and how potentially addressing social determinants of health as related to Alzheimer's disease can help improve diversity in trial enrollment.     We look forward to sharing our research and key learnings on this important topic at the Alzheimer’s Association International Conference (AAIC).     #AlzheimersDisease | #AlzheimersResearch | #AAIC24

We’re attending the Alzheimer’s Association International Conference (AAIC) in Philadelphia from July 28th through August 1st.     We look forward to connecting with the Alzheimer’s disease (AD) community and sharing the latest data across our portfolio on AD, a complex and debilitating disease impacting millions worldwide. Learn more about our research in AD: https://ow.ly/rIvj50SLm0J   #AAIC24 | #Biogen | #AlzheimersResearch 

Meet the future of STEM! Our RTP CoLab welcomed The Lady Cardinals to explore what’s possible with a career in science.    Hosting summer program participants is just one example of our long-standing efforts to build a diverse talent pipeline in North Carolina and beyond. Thanks to North Carolina Department of Commerce Secretary Machelle Baker Sanders, who created this program to drive gender equality in STEM jobs and earnings.    Explore the impact of Biogen’s CoLab: https://ow.ly/Es7Q50SKiWx   #STEMCareers | #WomenInSTEM | #CaringDeeply 

We’re proud of our very own Rachid Izzar for being named one of the newest members to its Board of Governors for The Alzheimer’s Drug Discovery Foundation.     Rachid, along with other key leaders, will work together to lend insights and continue to expand research and advancements to help the Alzheimer’s community.     Read more here: https://ow.ly/f17850SKmjt   #TeamBiogen | #AlzheimersDisease | #News

We were honored to engage with the Friedreich ataxia (FA) community at Friedreich's Ataxia Research Alliance (FARA)'s rideATAXIA events in Boston and Chicago, including the accompanying FA Research Reception in Chicago.    FARA’s rideATAXIA events are dedicated to spreading awareness of FA—a rare, life-shortening neuromuscular disease—and raising funds to advance scientific research. Their Research Receptions aim to educate and empower their community about research opportunities.    As we reminisce on two fantastic weekends spent with the community, we’re filled with renewed purpose to continue our work to help support the FA community. Learn more: https://ow.ly/o6yo50SIlgN   #FriedreichAtaxia | #TeamBiogen